Community-Based Provision of Statin and Aspirin After the Detection of Coronary Artery Calcium Within a Community-Based Screening Cohort
Allen J. Taylor, MD*, ,*,
Jody Bindeman, BSN*,
Irwin Feuerstein, MD*,,
Toan Le, ScD*,
Kelly Bauer, BSN*,
Carole Byrd, LVN*,
Holly Wu, MD* and
Patrick G. O’Malley, MD, MPH*,
* Departments of Medicine, Cardiology Service, Walter Reed Army Medical Center, Washington, DC
Uniformed Services University of the Health Sciences, Bethesda, Maryland.
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Incidence of Statin Use During 6-Year Actuarial Follow-Up in the PACC Project Cohort
Men only; n = 1,640. Ever-use of a statin was noted in 23% of participants, including 48.5% of those with coronary artery calcium and 15.5% of those without coronary artery calcium (p < 0.001), which remained significant after controlling for National Cholesterol Education Program risk variables (odds ratio 3.53; 95% confidence interval 2.66 to 4.69).
|
|
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Incidence of Aspirin Use During 6-Year Actuarial Follow-Up in the PACC Project Cohort
Men only; n = 1,640. Ever-use of aspirin was noted in 31.2% of participants, including 51.5% of those with coronary artery calcium versus 25.3% of those without coronary artery calcium (p < 0.001), which remained significant after controlling for National Cholesterol Education Program risk variables (odds ratio 3.05; 95% confidence interval 2.30 to 4.05).
|
|
|
